Reggie Bosma

617 total citations
18 papers, 267 citations indexed

About

Reggie Bosma is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Reggie Bosma has authored 18 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Immunology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Reggie Bosma's work include Receptor Mechanisms and Signaling (15 papers), Mast cells and histamine (8 papers) and Chemical Synthesis and Analysis (5 papers). Reggie Bosma is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Mast cells and histamine (8 papers) and Chemical Synthesis and Analysis (5 papers). Reggie Bosma collaborates with scholars based in Netherlands, United Kingdom and Germany. Reggie Bosma's co-authors include Rob Leurs, Henry F. Vischer, Chris de Graaf, Albert J. Kooistra, Stephen J. Hill, Leigh A. Stoddart, Stephen J. Briddon, Andrea J. Vernall, Luis Labeaga and Maikel Wijtmans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Reggie Bosma

17 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reggie Bosma Netherlands 11 183 63 61 39 31 18 267
Hannes Schihada Sweden 12 355 1.9× 42 0.7× 166 2.7× 46 1.2× 30 1.0× 25 394
Nicolas Villanueva United States 8 376 2.1× 51 0.8× 141 2.3× 50 1.3× 26 0.8× 13 476
Deep Chatterjee Germany 14 312 1.7× 18 0.3× 74 1.2× 25 0.6× 50 1.6× 28 463
Yuri Tomabechi Japan 15 403 2.2× 24 0.4× 72 1.2× 22 0.6× 33 1.1× 26 527
Stephanie Q. Hutsell United States 6 304 1.7× 16 0.3× 43 0.7× 19 0.5× 26 0.8× 7 372
Patricia Stege Germany 11 436 2.4× 44 0.7× 36 0.6× 19 0.5× 34 1.1× 14 552
Erich Goldbach United States 12 136 0.7× 61 1.0× 33 0.5× 40 1.0× 7 0.2× 19 366
Tory Schaaf United States 10 338 1.8× 63 1.0× 93 1.5× 26 0.7× 9 0.3× 16 487
Keith Smith United Kingdom 8 146 0.8× 31 0.5× 32 0.5× 29 0.7× 41 1.3× 11 257
Frank E. Kwarcinski United States 9 228 1.2× 17 0.3× 36 0.6× 48 1.2× 15 0.5× 18 310

Countries citing papers authored by Reggie Bosma

Since Specialization
Citations

This map shows the geographic impact of Reggie Bosma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reggie Bosma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reggie Bosma more than expected).

Fields of papers citing papers by Reggie Bosma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reggie Bosma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reggie Bosma. The network helps show where Reggie Bosma may publish in the future.

Co-authorship network of co-authors of Reggie Bosma

This figure shows the co-authorship network connecting the top 25 collaborators of Reggie Bosma. A scholar is included among the top collaborators of Reggie Bosma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reggie Bosma. Reggie Bosma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bosma, Reggie, Max Meyrath, Susanne M. A. van der Pol, et al.. (2025). Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840. Molecular Pharmacology. 107(12). 100085–100085. 1 indexed citations
2.
Roth, Susanne, Aurélien Rizk, Martin J. Lohse, et al.. (2025). Pharmacological characterization of a clinical candidate, TG-0054, a small molecule inverse agonist targeting CXCR4. Molecular Pharmacology. 107(4). 100015–100015.
3.
Bosma, Reggie, et al.. (2024). Multiplex Detection of Fluorescent Chemokine Binding to CXC Chemokine Receptors by NanoBRET. International Journal of Molecular Sciences. 25(9). 5018–5018. 2 indexed citations
4.
Shi, Shuang, Yang Zheng, Joëlle Goulding, et al.. (2024). A high-affinity, cis-on photoswitchable beta blocker to optically control β2-adrenergic receptors in vitro and in vivo. Biochemical Pharmacology. 226. 116396–116396. 3 indexed citations
5.
Bosma, Reggie, Barbara Zarzycka, Cédric Leyrat, et al.. (2024). Conformational dynamics underlying atypical chemokine receptor 3 activation. Proceedings of the National Academy of Sciences. 121(30). e2404000121–e2404000121. 14 indexed citations
6.
Bosma, Reggie, Albert J. Kooistra, Henry F. Vischer, et al.. (2024). Probing the Histamine H1 Receptor Binding Site to Explore Ligand Binding Kinetics. Journal of Medicinal Chemistry. 68(1). 448–464. 1 indexed citations
7.
Bosma, Reggie, Carl W. White, Laura E. Kilpatrick, et al.. (2023). NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET. Cell Reports Methods. 3(3). 100422–100422. 8 indexed citations
8.
Bosma, Reggie, et al.. (2022). BRET-Based Biosensors to Measure Agonist Efficacies in Histamine H1 Receptor-Mediated G Protein Activation, Signaling and Interactions with GRKs and β-Arrestins. International Journal of Molecular Sciences. 23(6). 3184–3184. 14 indexed citations
9.
Bosma, Reggie, Yang Zheng, Hannes Schihada, et al.. (2022). Optical control of the β2-adrenergic receptor with opto-prop-2: A cis-active azobenzene analog of propranolol. iScience. 25(9). 104882–104882. 11 indexed citations
10.
Wang, Zhiyong, Reggie Bosma, Henry F. Vischer, et al.. (2021). Exploring the Effect of Cyclization of Histamine H1 Receptor Antagonists on Ligand Binding Kinetics. ACS Omega. 6(19). 12755–12768. 4 indexed citations
11.
Bosma, Reggie, Leigh A. Stoddart, Victoria Georgi, et al.. (2019). Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor. Scientific Reports. 9(1). 7906–7906. 17 indexed citations
12.
Bosma, Reggie, Zhiyong Wang, Albert J. Kooistra, et al.. (2019). Route to Prolonged Residence Time at the Histamine H 1 Receptor: Growing from Desloratadine to Rupatadine. Journal of Medicinal Chemistry. 62(14). 6630–6644. 19 indexed citations
13.
Stoddart, Leigh A., Andrea J. Vernall, Reggie Bosma, et al.. (2018). Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells. Scientific Reports. 8(1). 1572–1572. 51 indexed citations
14.
Bosma, Reggie, et al.. (2018). The long duration of action of the second generation antihistamine bilastine coincides with its long residence time at the histamine H1 receptor. European Journal of Pharmacology. 838. 107–111. 26 indexed citations
15.
Bosma, Reggie, Gesa Witt, Lea Vaas, et al.. (2017). The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor. Frontiers in Pharmacology. 8. 667–667. 26 indexed citations
16.
Bosma, Reggie, et al.. (2016). BRET-based β-arrestin2 recruitment to the histamine H 1 receptor for investigating antihistamine binding kinetics. Pharmacological Research. 111. 679–687. 25 indexed citations
17.
Kooistra, Albert J., Reggie Bosma, Andrea Bortolato, et al.. (2016). Identification of Ligand Binding Hot Spots of the Histamine H 1 Receptor following Structure-Based Fragment Optimization. Journal of Medicinal Chemistry. 59(19). 9047–9061. 24 indexed citations
18.
Somarelli, Jason A., Daneen Schaeffer, Reggie Bosma, et al.. (2012). Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo. RNA. 19(1). 116–127. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannes Schihada Breakdown of academic impact, for papers by Nicolas Villanueva Breakdown of academic impact, for papers by Deep Chatterjee Breakdown of academic impact, for papers by Yuri Tomabechi Breakdown of academic impact, for papers by Stephanie Q. Hutsell Breakdown of academic impact, for papers by Patricia Stege Breakdown of academic impact, for papers by Erich Goldbach Breakdown of academic impact, for papers by Tory Schaaf Breakdown of academic impact, for papers by Keith Smith Breakdown of academic impact, for papers by Frank E. Kwarcinski
Rankless by CCL
2026